Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Absorption Kinetics: Capsules Versus Subcutaneous Delivery

Absorption rate determines tissue exposure duration, and the two delivery methods produce entirely different pharmacokinetic profiles. Subcutaneous injection creates a depot effect. The peptide sits in the subcutaneous space and gradually diffuses into circula

This comparison does not assign a generated winner or score.

  • Absorption rate determines tissue exposure duration, and the two delivery methods produce entirely different pharmacokinetic profiles. Subcutaneous injection creates a depot effect. The peptide sits in the subcutaneous space and gradually diffuses into circulation over 4–8 hours. This produces sustained plasma levels rather than a sharp spike. Oral capsules, by contrast, release BPC-157 into the gastrointestinal tract all at once. What survives gastric degradation moves rapidly through intestinal absorption, producing a brief, low-magnitude plasma elevation that drops quickly as hepatic metabolism clears the peptide.
  • A controlled study comparing oral versus subcutaneous delivery in animal models found that subcutaneous administration produced area-under-the-curve (AUC) values 4–6 times higher than oral dosing at equivalent milligram amounts. AUC measures total peptide exposure over time. It's the most accurate predictor of therapeutic effect in dose-response studies. The oral group showed peak plasma concentrations at 60–90 minutes post-administration, followed by rapid clearance. The subcutaneous group maintained detectable plasma levels for 6–8 hours.
  • Here's the honest answer: if systemic bioavailability matters for your research protocol, oral capsules are the wrong delivery method. The data is unambiguous. Capsules may have localized gastrointestinal effects. BPC-157 has demonstrated cytoprotective activity in gastric tissue even when orally administered. But systemic distribution to peripheral tissues, joints, or connective tissue requires injection. Researchers optimizing for convenience at the expense of bioavailability are introducing a variable that will confound results.
More references

Related material